Optimer Pharmaceuticals (OPTR) Tops Q1 EPS by 15c
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Price: $12.78 --0%
Financial Fact:
Income (loss) from operations: -27.12M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income (loss) from operations: -27.12M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q1 EPS of ($0.23), $0.15 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $28.77 million.
For earnings history and earnings-related data on Optimer Pharmaceuticals (OPTR) click here.
For earnings history and earnings-related data on Optimer Pharmaceuticals (OPTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
